This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
- Investigator
- Carla Zingariello
- Status
- Accepting Candidates
- Ages
- 12 Years - 50 Years
- Sexes
- All
Limb-girdle muscular dystrophies
Our locations
Clinical Trials: Limb-girdle muscular dystrophies
BOB体育 research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
News and Patient Stories: Limb-girdle muscular dystrophies
Study: Exome-sequencing has limited ability to diagnose limb-girdle muscular dystrophy
December 2, 2016
As medical technology advances, it can be tempting to assume that new genetic tools can accurately diagnose anything 鈥� but that鈥檚 not always the case. A鈥�
Department of Pediatrics, +4 more
